# MR Image Guided Therapy in Prostate Cancer

Source: https://onco.cc/trials/nct01377753/  
OnCo record `nct01377753` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Laser interstitial thermal therapy systems in Prostate cancer, run by National Cancer Institute (NCI), completed.

## Summary

MR Image Guided Therapy in Prostate Cancer is a phase 2 interventional study registered as NCT01377753 by National Cancer Institute (NCI), with 15 participants recorded, started 2011-08-12 and reaching its primary completion in 2017-01-01. Interventions recorded: Visualase Thermal Therapy System. Conditions recorded: Prostate Cancer, Prostatic Neoplasms.

Linked to the technology Laser interstitial thermal therapy systems because the registry names it ("visualase") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01377753
- Phase: 2
- Setting: MR Image Guided Focal Therapy in Prostate Cancer
- Sponsor: National Cancer Institute (NCI)
- Enrolled: 15

## Sources

- ClinicalTrials.gov NCT01377753: https://clinicaltrials.gov/study/NCT01377753

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Laser interstitial thermal therapy systems (NeuroBlate, Visualase)](https://onco.cc/technologies/litt-systems/)

---
JSON: https://onco.cc/api/v1/entities/nct01377753.json